TerrAscend (TSNDF) Total Current Liabilities (2021 - 2026)
TerrAscend (TSNDF) reported Total Current Liabilities of $67.7 million for Q1 2026, down 12.43% year-over-year from $77.3 million in Q1 2025, and down 15.33% quarter-over-quarter from $79.9 million in Q4 2025.
TerrAscend (TSNDF) Total Current Liabilities (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Total Current Liabilities data on file, last reported at $67.7 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $67.7 million, down 12.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $67.7 million (down 12.43% YoY), and the FY2025 annual result was $79.9 million, down 12.21% from the prior year.
- Total Current Liabilities eased to $67.7 million in Q1 2026 per TSNDF's latest filing, from $79.9 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $207.0 million in Q4 2023 and troughed at $67.7 million in Q1 2026.
- A 5-year average of $122.4 million and a median of $133.5 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities soared 108.36% in 2022, then slumped 61.18% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $137.9 million in 2022, then soared by 50.1% to $207.0 million in 2023, then plunged by 56.01% to $91.0 million in 2024, then dropped by 12.21% to $79.9 million in 2025, then fell by 15.33% to $67.7 million in 2026.
- Business Quant data shows TSNDF's Total Current Liabilities at $67.7 million in Q1 2026, $79.9 million in Q4 2025, and $76.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | 67.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.68 Mn |
| Dec 31, 2025 | 79.93 Mn |
| Sep 30, 2025 | 76.31 Mn |
| Jun 30, 2025 | 91.66 Mn |
| Mar 31, 2025 | 77.29 Mn |
| Dec 31, 2024 | 91.05 Mn |
| Sep 30, 2024 | 78.46 Mn |
| Jun 30, 2024 | 77.46 Mn |
| Mar 31, 2024 | 199.12 Mn |
| Dec 31, 2023 | 207.00 Mn |
| Sep 30, 2023 | 146.38 Mn |
| Jun 30, 2023 | 133.49 Mn |
| Mar 31, 2023 | 156.07 Mn |
| Dec 31, 2022 | 137.91 Mn |
| Sep 30, 2022 | 172.34 Mn |
| Jun 30, 2022 | 140.40 Mn |
| Mar 31, 2022 | 148.27 Mn |
| Dec 31, 2021 | 66.19 Mn |